By vgreene, 27 September, 2017 Sleep disturbance due to OSA fibromyalgia chronic pain or MS There s moderate evidence M that cannabinoids primarily nabiximols improve short term sleep outcomes 1
By vgreene, 27 September, 2017 Anorexia nervosa There s insufficient no evidence I N that cannabinoids are effective 1
By vgreene, 27 September, 2017 Schizophrenia or schizophreniform psychosis There s insufficient no evidence I N that CBD is effective for mental health outcomes 1
By vgreene, 27 September, 2017 Depression in chronic pain or MS pts Limited evidence L shows that nabilone no longer available in the U S nabiximols and dronabinol are ineffective for darr depressive sx in pts w chronic pain or MS 1
By vgreene, 27 September, 2017 PTSD There s limited evidence L from a single small fair quality trial that nabilone no longer available in the U S is effective per NAS 1 A VA commissioned review2 found insufficient evidence lack of efficacy trials on cannabis for PTSD and notes that in
By vgreene, 27 September, 2017 Anxiety Evidence is limited L that CBD is effective for improving anxiety sx as assessed by a public speaking test in individuals w social anxiety disorders 1
